Skip to Content

Notice

Manufacturer of Controlled Substances Registration: Siegfried (USA), LLC

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 31988

ACTION:

Notice of registration.

SUMMARY:

Siegfried (USA), LLC applied to be registered as a manufacturer of certain basic classes of narcotic or non-narcotic controlled substances. The DEA grants Siegfried (USA), LLC registration as a manufacturer of those controlled substances.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

By notice dated December 23, 2013, and published in the Federal Register on January 8, 2014, 79 FR 1391, Siegfried (USA), LLC, 33 Industrial Park Road, Pennsville, New Jersey 08070, applied to be registered as a manufacturer of certain basic classes of narcotic or non-narcotic controlled substances.

The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Siegfried (USA), LLC to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verified the company's compliance with state and local laws, and reviewed the company's background and history.

Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of narcotic or non-narcotic controlled substances listed:

Controlled substanceSchedule
Gamma Hydroxybutyric Acid (2010)I
Dihydromorphine (9145)I
Hydromorphinol (9301)I
Methylphenidate (1724)II
Amobarbital (2125)II
Pentobarbital (2270)II
Secobarbital (2315)II
Codeine (9050)II
Oxycodone (9143)II
Hydromorphone (9150)II
Hydrocodone (9193)II
Meperidine (9230)II
Methadone (9250)II
Methadone intermediate (9254)II
Dextropropoxyphene, bulk (9273)II
Morphine (9300)II
Oripavine (9330)II
Thebaine (9333)II
Opium tincture (9630)II
Oxymorphone (9652)II

The company plans on manufacturing the listed controlled substances in bulk for distribution to its customers.

No comments or objections have been received.

Start Signature

Dated: May 28, 2014.

Joseph T. Rannazzisi,

Deputy Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2014-12796 Filed 6-2-14; 8:45 am]

BILLING CODE 4410-09-P